Literature DB >> 10745246

High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype.

V H Aquino1, L T Figueiredo.   

Abstract

A prospective analysis of cytomegalovirus (CMV) glycoprotein B (gB) genotypes was conducted on 34 renal transplant recipients using peripheral blood leukocytes (PBLs) and urine specimens. The CMV gB genotypes were analyzed by polymerase chain reaction (PCR) followed by enzyme digestion. PBLs and urine samples showed almost equal proportions of the 4 known gB genotypes, as well as equal proportions of gB genotype mixtures. The gB genotypes 1, 2 and 3 were equally distributed in the patients. Twenty-four (70.6%) patients had more than one gB genotype during follow-up. There was no association of gB genotypes with the development of symptomatic CMV infection. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10745246

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes.

Authors:  Jutte J C de Vries; Els Wessels; Anna M H Korver; Annemiek A van der Eijk; Lisette G Rusman; Aloys C M Kroes; Ann C T M Vossen
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  Errors in published sequences of human cytomegalovirus primers and probes: do we need more quality control?

Authors:  Wafa Habbal; Fawza Monem; Barbara Christine Gärtner
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Analysis of the variability of CMV strains in the RL11D domain of the RL11 multigene family.

Authors:  Karin Sekulin; Irene Görzer; Dorothea Heiss-Czedik; Elisabeth Puchhammer-Stöckl
Journal:  Virus Genes       Date:  2007-09-01       Impact factor: 2.332

4.  Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host.

Authors:  Luka Cicin-Sain; Jürgen Podlech; Martin Messerle; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.

Authors:  Zhongde Wang; Corinna La Rosa; Rebecca Maas; Heang Ly; John Brewer; Shahram Mekhoubad; Pirouz Daftarian; Jeff Longmate; William J Britt; Don J Diamond
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B.

Authors:  Fan Jun; Li Minhuan; Ma Yadan; Huang Yaping; Liang Hanying; Hu Jianhua; Yao Hangping; Ma Weihang
Journal:  Braz J Med Biol Res       Date:  2012-05-24       Impact factor: 2.590

Review 7.  Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.

Authors:  Hsuan-Yuan Wang; Sarah M Valencia; Susanne P Pfeifer; Jeffrey D Jensen; Timothy F Kowalik; Sallie R Permar
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.